AMPLIPHI BIOSCIENCES Announces First Closing of $2.7m.

Extract


AMPLIPHI BIOSCIENCES Announces First Closing of $2.7m.

RICHMOND, Va. & SEATTLE, Wa. & COLWORTH, UK -- AmpliPhi Biosciences Corporation (APHB.PK), the leader in the development of bacteriophage-based anti-bacterial therapies to treat drug resistant infections, has announced that is has closed on an initial amount of $...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company